Moreover, ET-1-stimulated or EC CM-treated HG-SOC cells displayed a higher tumor migration rate, that was inhibited by macitentan or EC CM that had been previously depleted of YAP, HIF-1α or p53 (Supplementary Fig. 4F). The gene discussed is TP53; the disease is neoplasm.